全基因组结构变异分析确定了非阿尔茨海默氏症痴呆症的风险位置
Karri Kaivola1, Ruth Chia2, Jinhui Ding3
1Neurodegenerative Diseases Research Unit, National Institute of Neurological Disorders and Stroke, Bethesda, MD, USA.
Cell genomics
|June 30, 2023
概括
这项研究探讨了勒维体痴呆症 (LBD) 和前性痴呆症 / 性侧面硬化症 (FTD / ALS) 的结构性遗传变异. 一个新的TPCN1删除与LBD风险有关,推进了痴呆症研究.
科学领域:
- 遗传学 是一个遗传学.
- 神经科学是一个神经科学.
- 基因组医学是基因组医学.
背景情况:
- 结构变异 (SV) 是研究不足的遗传变异.
- 莱维体痴呆症 (LBD) 和前性痴呆症/肌性侧面硬化症 (FTD/ALS) 是不同的神经退行性疾病.
- 了解非阿尔茨海默氏症痴呆症的遗传基础至关重要.
研究的目的:
- 调查SVs在LBD和FTD/ALS中的作用.
- 确定这些痴呆症的新型遗传风险因素.
- 为未来的研究创建一个SVs目录.
主要方法:
- 将GATK-SV管道应用于全基因组测序数据.
- 分析了5,213个欧洲血统病例和4,132个对照病例的数据.
- 使用发现,复制和验证策略.
主要成果:
- 确定了与LBD风险相关的TPCN1中的新删除.
- 在FTD/ALS.中的C9orf72和MAPT位点确认已知的SVs.
- 在LBD和FTD/ALS队列中发现了罕见的致病性SV.
结论:
- 结构变异在LBD和FTD/ALS病变发生过程中起着重要作用.
- TPCN1代表了LBD的一个新的潜在风险场所.
- 生成的SV目录将有助于未来研究这些痴呆症.
关键词:
莱维体痴呆症 (Lewy体痴呆症) 是一种疾病.骨髓缩侧面硬化症 (ALS) 是一种个案控制研究研究.前性痴呆症前性痴呆症全基因组关联研究研究.没有阿尔茨海默氏症痴呆症这是资源资源.结构变体结构变体更多相关视频
11:35Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA
Published on: August 21, 2016
13.0K
09:34Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
33.8K
相关概念视频
Genome-wide Association Studies-GWAS
13.6K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
13.6K
Comparing Copy Number Variations and SNPs
17.8K
Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
17.8K
Single Nucleotide Polymorphisms-SNPs
15.3K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
15.3K
Histone Variants at the Centromere
4.4K
Histone variants are the histone proteins with structural and sequence variations. These variants may be regarded as “mutant” forms that replace their canonical histone counterparts in the nucleosomes. Specific post-translational modifications on the histone variants enable further chromatin complexity and regulate tissue-specific gene expression. The most common histone variants are from histone H2A, H2B, and linker histone H1 families. However, several variants of histone H3...
4.4K
